{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T08:27:30Z","timestamp":1769502450519,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,26]]},"DOI":"10.7759\/cureus.102334","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T21:26:35Z","timestamp":1769462795000},"source":"Crossref","is-referenced-by-count":0,"title":["Drug-Resistant Early-Onset Progressive Myoclonic Epilepsy Revealing Lafora Disease: A Case Report"],"prefix":"10.7759","author":[{"given":"Natasa","family":"Pejanovic-Skobic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijana","family":"Demirovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Boban Raguz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Bender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davor","family":"Batinic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolina","family":"Pravdic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Progressive myoclonus epilepsy of Lafora","author":"Serratosa JM","year":"2012","unstructured":"Serratosa JM, Minassian BA, Ganesh S. Progressive myoclonus epilepsy of Lafora. Jasper's Basic Mechanisms of the Epilepsies [Internet]. 4th edition. Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV (ed): National Center for Biotechnology Information (US), Bethesda, MD; 2012. 874-7."},{"key":"ref2","article-title":"Progressive myoclonus epilepsy, Lafora type","author":"Minassian B","year":"2025","unstructured":"Minassian B. Progressive myoclonus epilepsy, Lafora type. GeneReviews\u00ae. Adam MP, Bick S, Mirzaa GM, et al. (ed): University of Washington, Seattle, WA; 2025."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1684\/epd.2016.0842","article-title":"Lafora disease","volume":"18","author":"Turnbull J","year":"2016","unstructured":"Turnbull J, Tiberia E, Striano P, Genton P, Carpenter S, Ackerley CA, Minassian BA. Lafora disease. Epileptic Disord. 2016, 18:38-62. 10.1684\/epd.2016.0842","journal-title":"Epileptic Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneuro0706","article-title":"Typical progression of myoclonic epilepsy of the Lafora type: a case report","volume":"4","author":"Striano P","year":"2008","unstructured":"Striano P, Zara F, Turnbull J, et al.. Typical progression of myoclonic epilepsy of the Lafora type: a case report. Nat Clin Pract Neurol. 2008, 4:106-11. 10.1038\/ncpneuro0706","journal-title":"Nat Clin Pract Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.40.9.671","article-title":"Genetic mapping of a new Lafora progressive myoclonus epilepsy locus (EPM2B) on 6p22","volume":"40","author":"Chan EM","year":"2003","unstructured":"Chan EM, Bulman DE, Paterson AD, et al.. Genetic mapping of a new Lafora progressive myoclonus epilepsy locus (EPM2B) on 6p22. J Med Genet. 2003, 40:671-5. 10.1136\/jmg.40.9.671","journal-title":"J Med Genet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/ng1238","article-title":"Mutations in NHLRC1 cause progressive myoclonus epilepsy","volume":"35","author":"Chan EM","year":"2003","unstructured":"Chan EM, Young EJ, Ianzano L, et al.. Mutations in NHLRC1 cause progressive myoclonus epilepsy. Nat Genet. 2003, 35:125-7. 10.1038\/ng1238","journal-title":"Nat Genet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.6793","article-title":"Lafora disease: report of a rare entity","volume":"12","author":"Al Mufargi Y","year":"2020","unstructured":"Al Mufargi Y, Qureshi A, Al Asmi A. Lafora disease: report of a rare entity. Cureus. 2020, 12:e6793. 10.7759\/cureus.6793","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/11.11.1263","article-title":"Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype","volume":"11","author":"Ganesh S","year":"2002","unstructured":"Ganesh S, Delgado-Escueta AV, Suzuki T, et al.. Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype. Hum Mol Genet. 2002, 11:1263-71. 10.1093\/hmg\/11.11.1263","journal-title":"Hum Mol Genet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00526.x","article-title":"MRI volumetry and proton MR spectroscopy of the brain in Lafora disease","volume":"47","author":"Villanueva V","year":"2006","unstructured":"Villanueva V, Alvarez-Linera J, G\u00f3mez-Garre P, Guti\u00e9rrez J, Serratosa JM. MRI volumetry and proton MR spectroscopy of the brain in Lafora disease. Epilepsia. 2006, 47:788-92. 10.1111\/j.1528-1167.2006.00526.x","journal-title":"Epilepsia"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae104","article-title":"(1)H and (31)P magnetic resonance spectroscopy reveals potential pathogenic and biomarker metabolite alterations in Lafora disease","volume":"6","author":"Chan KL","year":"2024","unstructured":"Chan KL, Panatpur A, Messahel S, et al.. (1)H and (31)P magnetic resonance spectroscopy reveals potential pathogenic and biomarker metabolite alterations in Lafora disease. Brain Commun. 2024, 6:fcae104. 10.1093\/braincomms\/fcae104","journal-title":"Brain Commun"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebcr.2013.08.002","article-title":"Vagus nerve stimulation in Lafora body disease","volume":"1","author":"Hajnsek S","year":"2013","unstructured":"Hajnsek S, Petelin Gadze Z, Borovecki F, et al.. Vagus nerve stimulation in Lafora body disease. Epilepsy Behav Case Rep. 2013, 1:150-2. 10.1016\/j.ebcr.2013.08.002","journal-title":"Epilepsy Behav Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1684\/epd.2017.0892","article-title":"Managing Lafora body disease with vagal nerve stimulation","volume":"19","author":"Mikati MA","year":"2017","unstructured":"Mikati MA, Tabbara F. Managing Lafora body disease with vagal nerve stimulation. Epileptic Disord. 2017, 19:82-6. 10.1684\/epd.2017.0892","journal-title":"Epileptic Disord"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2010.12.042","article-title":"Efficacy of vagus nerve stimulation over time: review of 65 consecutive patients with treatment-resistant epilepsy treated with VNS >10 years","volume":"20","author":"Elliott RE","year":"2011","unstructured":"Elliott RE, Morsi A, Tanweer O, et al.. Efficacy of vagus nerve stimulation over time: review of 65 consecutive patients with treatment-resistant epilepsy treated with VNS &gt;10 years. Epilepsy Behav. 2011, 20:478-83. 10.1016\/j.yebeh.2010.12.042","journal-title":"Epilepsy Behav"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws205","article-title":"Early-onset Lafora body disease","volume":"135","author":"Turnbull J","year":"2012","unstructured":"Turnbull J, Girard JM, Lohi H, et al.. Early-onset Lafora body disease. Brain. 2012, 135:2684-98. 10.1093\/brain\/aws205","journal-title":"Brain"},{"key":"ref15","article-title":"Lafora disease during a seven-year period: Bosnian and Herzegovinian experience","volume":"13","author":"Begic E","year":"2019","unstructured":"Begic E, Bradaric H, Begic Z, Dobraca A. Lafora disease during a seven-year period: Bosnian and Herzegovinian experience. Iran J Child Neurol. 2019, 13:115-20.","journal-title":"Iran J Child Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/457193-drug-resistant-early-onset-progressive-myoclonic-epilepsy-revealing-lafora-disease-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T21:26:36Z","timestamp":1769462796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/457193-drug-resistant-early-onset-progressive-myoclonic-epilepsy-revealing-lafora-disease-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.102334","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,26]]}}}